Skip to main content
Axogen, Inc. logo

Axogen, Inc. — Investor Relations & Filings

Ticker · AXGN ISIN · US05463X1063 US Manufacturing
Filings indexed 1,144 across all filing types
Latest filing 2026-05-07 Major Shareholding Noti…
Country US United States of America
Listing US AXGN

About Axogen, Inc.

https://www.axogeninc.com/

Axogen, Inc. is a regenerative medicine company focused on developing and commercializing surgical solutions for peripheral nerve repair. The company provides technologies designed to restore sensation and functionality to individuals with damaged peripheral nerves. Its portfolio is centered on products that facilitate nerve regeneration and repair, such as the Avance® Nerve Graft, a processed human nerve allograft for bridging nerve gaps. Axogen's solutions are utilized by surgeons to treat patients with nerve injuries resulting from trauma or other medical conditions, aiming to improve their quality of life by restoring function and reducing pain.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-07 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-29 English
ARS - Axogen, Inc. (0000805928) (Filer)
Annual Report
2026-04-29 English
AXGN DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2026-04-29 English
10-Q - Axogen, Inc. (0000805928) (Filer)
Interim / Quarterly Report Q1 2026
2026-04-28 English
8-K - Axogen, Inc. (0000805928) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text specifically mentions the issuance of a press release announcing first quarter 2026 financial results and the posting of financial results and corporate presentations on the company's website. The document includes references to an earnings press release and presentations but does not contain the full financial statements or detailed financial analysis itself. The document is about announcing the earnings release and related presentations rather than being the earnings release or the full quarterly report itself. Given the nature of the Form 8-K and the content, this is best classified as an Earnings Release (ER) announcement, as it primarily announces the quarterly financial results and related materials. Confidence is high because the document explicitly states it is furnishing the earnings press release and presentations and is a typical 8-K earnings announcement.
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.